Abstract: A method for treating an inflammation or lesion caused by herpes virus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as Herpes simplex. Nasal deliverable forms are effective in treating symptoms due to viruses that cause the common cold. Pharmaceutical compositions for use in the present method are provided.
Type:
Application
Filed:
June 15, 2011
Publication date:
April 19, 2012
Applicant:
LIFE FORCE TECHNOLOGIES, LLC
Inventors:
Thomas W. Konowalchuk, Jack Konowalchuk
Abstract: A method for treating an inflammation or lesion caused by herpesvirus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as herpes simplex. Nasal deliverable forms are effective in treating symptoms due to viruses that cause the common cold. Pharmaceutical compositions for use in the present method are provided.
Type:
Grant
Filed:
March 27, 2006
Date of Patent:
July 19, 2011
Assignee:
Life Force Technologies, LLC
Inventors:
Thomas W. Konowalchuk, Jack Konowalchuk
Abstract: A method for preventing lesions caused by a virus of the Herpesviridae or Poxviridae family, comprising topically applying a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as herpes simplex. Pharmaceutical compositions for use in the present method are provided.
Type:
Grant
Filed:
December 6, 2001
Date of Patent:
March 8, 2011
Assignee:
Life Force Technologies, LLC
Inventors:
Thomas W. Konowalchuk, Jack Konowalchuk